Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: Assessment with ACTH profiles

Hormone and Metabolic Research

Volumn 42, Issue 13, 2010, Pages 961-966

  Ekman, B ^a   Blomgren, J ^b   Andersson, P O ^b   Carlsson, M ^c   Arnqvist, H J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Internal Medicine County Hospital   (Sweden)

^c KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

ACTH; adrenal insufficiency; cortisol; cortisone

Indexed keywords

CORTICOTROPIN; CORTISONE ACETATE; GLUCOCORTICOID; HYDROCORTISONE;

ADDISON DISEASE; ADULT; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; HORMONE ACTION; HORMONE URINE LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; SALIVA LEVEL;

ADDISON DISEASE; ADRENOCORTICOTROPIC HORMONE; ADULT; CORTISONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; SALIVA; TIME FACTORS;

EID: 78649903696     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1265218     Document Type: Article

References (30)

1. Oelkers W, Diederich S, Bahr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992 75 259-264
2. Besser GM, Jeffcoate WJ. Endocrine and metabolic diseases. Adrenal diseases. Br Med J 1976 1 448-451
3. Oelkers W. Adrenal insufficiency. N Engl J Med 1996 335 1206-1212
4. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893
5. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001 86 2909-2922
6. Debono M, Ross RJ, Newell-Price J. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 2009 160 719-729
7. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) 1981 14 451-458
8. Laureti S, Falorni A, Santeusanio F. Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in 3 daily doses. J Endocrinol Invest 2003 26 1071-1075
9. Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol (Oxf) 1978 9 571-576
10. Lewis JG, Mopert B, Shand BI, Doogue MP, Soule SG, Frampton CM, Elder PA. Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin. Horm Metab Res 2006 38 241-245
11. Rosner W. Plasma steroid-binding proteins. Endocrinol Metab Clin North Am 1991 20 697-720
12. Holder G. Measurement of glucocorticoids in biological fluids. Methods Mol Biol 2006 324 141-157
13. Hiramatsu R. Direct assay of cortisol in human saliva by solid phase radioimmunoassay and its clinical applications. Clin Chim Acta 1981 117 239-249
14. Read GF, Walker RF, Wilson DW, Griffiths K. Steroid analysis in saliva for the assessment of endocrine function. Ann N Y Acad Sci 1990 595 260-274
15. Holdaway IM. Suppression of plasma ACTH levels with corticosteroids in Addison's disease. Clin Endocrinol (Oxf) 1973 2 37-42
16. Baid SK, Rubino D, Sinaii N, Ramsey S, Frank A, Nieman LK. Specificity of screening tests for Cushing's syndrome in an overweight and obese population. J Clin Endocrinol Metab 2009 94 3857-3864
17. Blomgren J, Ekman B, Andersson PO, Arnqvist HJ. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution. Scand J Clin Lab Invest 2004 64 132-139
18. Jenkins JS, Sampson PA. Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J 1967 2 205-207
19. Colburn WA, DiSanto AR, Stubbs SS, Monovich RE, DeSante KA. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a single oral administration of cortisone acetate to human subjects. J Clin Pharmacol 1980 20 428-436
20. Srivastava LS, Werk EE Jr, Thrasher K, Sholiton LJ, Kozera R, Nolten W, Knowles HC, Jr. Plasma cortisone concentration as measured by radioimmunoassay. J Clin Endocrinol Metab 1973 36 937-943
21. Turner AK, Carroll CJ, Pinkus JL, Charles D, Chattoraj SC. Simultaneous competitive protein binding assay for cortisol, cortisone, and prednisolone in plasma, and its clinical application. Clin Chem 1973 19 731-736
22. Heazelwood VJ, Galligan JP, Cannell GR, Bochner F, Mortimer RH. Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. Br J Clin Pharmacol 1984 17 55-59
23. Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-h cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 2004 89 281-287
24. Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004 61 367-375
25. Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA. Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 2004 46 39-46
26. Lovas K, Thorsen TE, Husebye ES. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. J Endocrinol Invest 2006 29 727-731
27. Lovas K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 2002 56 581-588
28. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006 91 4849-4853
29. Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W, Ross RJ. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab 2009 94 1548-1554
30. Johannsson G, Bergthorsdottir R, Nilsson A, Lennemas H, Hedner T, Skrtic S. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol 2009 161 119-130